Drugs

Rosebud's Ranch and Garden, LLC

FDA issued a warning letter to Rosebud's Ranch and Garden, LLC (Piqua, OH, United States) on Oct 18, 2022, citing 21 CFR 201.5. Subject: New Drug, Misbranded.

From the letter: “The claims on your websites establish the products are drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. 321(g)(1)(B)] because they are intended for use in the cure, mitigation, treatment, or…”

Piqua, OH, United StatesIssued Oct 18, 2022Posted Nov 22, 2022Close-out Apr 7, 2023

FDA published a close-out letter on Apr 7, 2023. The findings below are from the original warning letter.

At a glance

What a reviewer notes before reading: findings, citations, the response deadline and what the letter warns of.

Violations
2 findings · 1 issue type
Response due
15 working days after receipt of this letter
FDA asks for
3 actions
Named as possible actions
Seizure, injunction
Issued by
Division of Human and Animal Food Operations East V · Office of Inspections and Investigations
Published status
Close-out Apr 7, 2023

AI assisted findings

Model-assisted reading of each issue. Open one to see the FDA text it comes from, and check it against the full letter.

01Labeling, claims & marketingProducts are unapproved new drugs due to disease treatment claims on websites and social media.
The claims on your websites establish the products are drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. 321(g)(1)(B)] because they are intended for use in the cure, mitigation, treatment, or prevention of disease.
02Labeling, claims & marketingProducts are misbranded because they lack adequate directions for use for disease treatment.
Your products are not generally recognized as safe and effective for the above referenced uses and, therefore, the products are “new drugs” under section 201(p) of the Act [21 U.S.C. 321(p)].

What FDA requested

  • Provide specific steps taken to address the violations, including an explanation of each step to prevent recurrence and copies of related documentation
  • If corrective actions cannot be completed within 15 working days, state the reason for the delay and the time within which they will be completed
  • If you believe the products are not in violation, include reasoning and supporting information

FDA Warning Letter

47 paragraphs · 1 section

Text as published on FDA.gov, retrieved Sep 8, 2026. Layout added for reading; the wording is FDA’s. View on FDA.gov (opens in a new tab)

Sent to10/18/2022
AddressedDear Ms. Stephenson

1Letter text

42 paragraphs

This is to advise you that the Food and Drug Administration (FDA) reviewed your website at the Internet address www.rosebudsrealfood.com and your social media website at www.facebook.com/RosebudsRealFood in June and August 2022, from which sites you take orders for Domestic Divas – Colds and Flu (Tea), Domestic Divas - No Pain No Gain Tea, Green Feather Homestead Mad As A Hatter Chai Tea, Rosebud’s Natural Seasonings Elderberry Syrup Kit, Rosebud’s Elderberry Lemonade, Rosebud’s Herbs & Spices Sencha Tea, Rosebud’s Natural Seasonings Jane’s Italian, Rosebud’s Fruit Butters Peach Blueberry, Rosebud’s Real Food Raw! Habanero Sriracha, and Rosebud’s Real Food Supertonic! Sriracha. The claims on your websites establish the products are drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. 321(g)(1)(B)] because they are intended for use in the cure, mitigation, treatment, or prevention of disease. As explained further below, introducing or delivering these products for introduction into interstate commerce for such uses violates the Act. You can find the FD&C Act and FDA regulations through links on FDA’s home page at www.fda.gov.

Examples of some of the claims that provide evidence that your products are intended for use as drugs include:

Domestic Divas - Colds and Flu (Tea) “Eases the discomfort of a cold or flu”

Domestic Divas - No Pain No Gain Tea “Eases Muscular Pain”

Green Feather Homestead Mad As A Hatter Chai Tea “balancing to blood sugar” Rosebud’s Natural Seasonings Elderberry Syrup Kit: From the product label, as shown on an image on your website at www.rosebudsrealfood.com/products/elderberry-syrupkit?_pos=1&_sid=4f1ea37c2&_ss=r:

“Standard dose is ½ tsp - 1 tsp for kids and ½ - 1 tablespoon for adults. If the flu does strike, take the normal dose every 2-3 hours instead of once a day until symptoms disappear”

Rosebud’s Elderberry Lemonade, Rosebud’s Natural Seasonings Elderberry Syrup Kit (Elderberry ingredient): www.facebook.com/RosebudsRealFood

Facebook Post Date February 3, 2022

“‘Health benefits of the elder plant [elderberry] include naturally improving sinus issues, nerve pain, inflammation, chronic fatigue, allergies, constipation and even cancer. When used within the first 48 hours of onset of symptoms, the extract may even help relieve and shorten the duration of cold and flu symptoms as well.”

Facebook Post Date September 3, 2021

“Cancer Preventer”

“Blood Sugar Balancer”

“Cold & Flu Fighter”

Rosebud’s Herbs & Spices Sencha Tea: www.facebook.com/RosebudsRealFood

Facebook Post Date January 4, 2022

“Potential benefits of sencha green tea include:

anti-cancer properties

prevention of neurodegenerative diseases

anti-inflammatory properties

lowering bad cholesterol

anti-bacterial properties

prevention of some bacterial and virus infections

preventing tooth decay”

Real Food Raw! Habanero Sriracha, Natural Seasonings Jane’s Italian, and Real Food Supertonic! Sriracha (all of which contain garlic as an ingredient): www.facebook.com/RosebudsRealFood

Facebook Post Date January 22, 2022

“Garlic is antiviral, antibacterial, antifungal (including anti-mold), anti-parasitic, and rich in the phytochemical allicin, a sulfur compound that prevents disease.”

“Garlic kills off pathogens such as viruses and unproductive bacteria, which are behind so many mystery and chronic illnesses and symptoms.”

“Garlic helps fight colds, flus, strep throat, pneumonia-causing bacteria, and viral-related cancers.”

Facebook Post Date January 9, 2022

“Eat some garlic and lower that blood pressure!”

“Garlic has anti-inflammatory benefits and helps blood flow more easily through the body. Several studies found that blood pressure was lowered by 10%!!!!”

Rosebud’s Elderberry Lemonade and Rosebud’s Fruit Butters Peach Blueberry (which contain lemon): www.facebook.com/RosebudsRealFood

Facebook Post Date February 19, 2022

“[P]hytochemicals called limonoids in lemons and limes actually bond the vitamin C and calcium together, so that wherever one goes in the body, the other rides along. This enhances the bioavailability of each, and also creates alkalinity in the body to help prevent the growth of almost every type of cancer”

“The antioxidant flavonoids in lemons and limes are another ally in fighting disease. And when you’re dealing with a cold, flu, bronchitis, or pneumonia, lemon is one of the most effective mucus expellers you can find.”

Your products are not generally recognized as safe and effective for the above referenced uses and, therefore, the products are “new drugs” under section 201(p) of the Act [21 U.S.C. 321(p)]. With certain exceptions not applicable here, new drugs may not be legally introduced or delivered for introduction into interstate commerce without prior approval from FDA, as described in sections 301(d) and 505(a) of the Act [21 U.S.C. 331(d), 355(a)]. FDA approves a new drug on the basis of scientific data and information demonstrating that the drug is safe and effective.

A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). “Adequate directions for use” means directions under which a layperson can use a drug safely and for the purposes for which it is intended (21 CFR 201.5). Prescription drugs, as defined in section 503(b)(1)(A) of the Act [21 U.S.C. 353(b)(1)(A)], can only be used safely at the direction, and under the supervision, of a licensed practitioner.

Your products Rosebud’s Natural Seasonings Elderberry Syrup Kit, Rosebud’s Elderberry Lemonade, Rosebud’s Real Food Raw! Habanero Sriracha, Rosebud’s Natural Seasonings Jane’s Italian, Rosebud’s Fruit Butters Peach Blueberry, Rosebud’s Herbs & Spices Sencha Tea and Rosebud’s Real Food Supertonic! Sriracha are intended for treatment of one or more diseases that are not amenable to self-diagnosis or treatment without the supervision of a licensed practitioner. Therefore, it is impossible to write adequate directions for a layperson to use your product safely for its intended purpose. Accordingly, Rosebud’s Natural Seasonings Elderberry Syrup Kit, Rosebud’s Elderberry Lemonade, Rosebud’s Real Food Raw! Habanero Sriracha, Rosebud’s Natural Seasonings Jane’s Italian, Rosebud’s Fruit Butters Peach Blueberry, Rosebud’s Herbs & Spices Sencha Tea, and Rosebud’s Real Food Supertonic! Sriracha fail to bear adequate directions for their intended use and, therefore, the products are misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)]. The introduction or delivery for introduction into interstate commerce of these misbranded drugs violates section 301(a) of the Act [21 U.S.C. 331(a)].

This letter is not intended to be an all-inclusive statement of violations that may exist in connection with your products. You are responsible for investigating and determining the causes of any violations and for preventing their recurrence or the occurrence of other violations. It is your responsibility to ensure that your firm complies with all requirements of federal law, including FDA regulations.

This letter notifies you of our concerns and provides you an opportunity to address them. Failure to adequately address this matter may result in legal action including, without limitation, seizure and injunction.

Please notify FDA in writing, within 15 working days of receipt of this letter, of the specific steps you have taken to address any violations. Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentation. If you cannot complete corrective actions within 15 working days, state the reason for the delay and the time within which you will do so. If you believe that your products are not in violation of the Act, include your reasoning and any supporting information for our consideration.

Your reply should be addressed to the U.S. Food and Drug Administration; Attn: Christopher N. Dedeaux, Compliance Officer, via email at ORAHAFEAST5FirmResponses@fda.hhs.gov or at 404 BNA Drive, Suite 500, Nashville, TN 37217. You may reach Mr. Dedeaux at 504-846-6122 or via email at Christopher.Dedeaux@fda.hhs.gov if you have any questions about this matter.

Sincerely, /S/

Steven B. Barber Director, Division V Office of Human and Animal Foods Operations-East

Citations and trends

Each 21 CFR section, ISO 13485 clause and issue type in this letter, how often it appears across all letters, and its trend by the year FDA issued the letters. 2026 runs to Nov 3, 2026, compared with the same dates last year. Select a row or a bar to see those letters in Letters. As cited in this historical letter, not a statement of current requirements.

Regulations

Issue types

Record details

Issuing center
Office of Inspections and Investigations
Issuing office
Division of Human and Animal Food Operations East V
Location
Piqua, OH, United States
Letter posted date
Nov 22, 2022
Letter issue date
Oct 18, 2022
Addressed to
Owner
Inspection dates
Not recorded
Response window
15 working days after receipt of this letter
Read the source clause
Please notify FDA in writing, within 15 working days of receipt of this letter, of the specific steps you have taken to address any violations.
Record length
1,246 words · 2 recorded redactions
Published status
Close-out published Apr 7, 2023
Original letter
View on FDA.gov (opens in a new tab)
Dataset last checked
Nov 11, 2026 · How this is built

A response window is not a calculated due date. Source excerpts are selected passages. Finding interpretations and categories are model-assisted. Verify the original letter before relying on a finding.

See the pattern across 1,707 lettersFind letters like this →
Keep exploring

More drug letters

Recent records for the same product type. Your previous filters remain available when you return.

Keep exploring

Find letters like this →
For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

Every letter by dateHow this database is built

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.